Advancement in exosome-based cancer therapeutics: A new era in cancer treatment

8Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

In the modern era of rapid development and advancement in cancer therapeutics and management, there is a growing awareness in the application of exosomes as a potential tool to target cancer cells. Exosomes are cell-derived nano-vesicles that modulate intercellular communications and transport. Due to their ideal native structure and characteristics, exosomes have emerged as a promising nanocarrier for clinical use. Nevertheless, their medical application is coupled with some intrinsic restrictions which hinder their widespread use. In order to make exosomes more effective, they are engineered at the cellular level to develop designer exosomes. The focus of this review is to summarize the various exosome bio-engineering approaches aimed at the development of designer exosomes and their application in cancer treatment.

Cite

CITATION STYLE

APA

Dutta, A., & Paul, S. (2022, August 4). Advancement in exosome-based cancer therapeutics: A new era in cancer treatment. Frontiers in Nanotechnology. Frontiers Media S.A. https://doi.org/10.3389/fnano.2022.939197

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free